Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Acta Reumatol Port ; 36(4): 364-9, 2011.
Article in English | MEDLINE | ID: mdl-22472926

ABSTRACT

OBJECTIVE: Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic symmetric polyarthritis causing progressive joint destruction and disability. Major patient complaints are pain, disability and fatigue. The aim of this study is to assess fatigue and its association with disease-specific variables (severity of pain, disease activity, and functional status) in patients with RA. PATIENTS AND METHODS: A total of 160 RA patients were included in the study. Fatigue was measured by using Fatigue Symptom Inventory (FSI). The quadrivariate Disease Activity Score-28 (DAS28) was used for evaluating disease activity and Health Assessment Questionnaire (HAQ) for determining functional status. Severity of pain was measured by using 10 cm Visual Analog Scale-Pain (VAS-pain). RESULTS: Intensity items of FSI (most fatigue, least fatigue, average fatigue, current fatigue) were strongly correlated with DAS28, HAQ, and VAS pain (p=0.000). When the correlation coefficients were analyzed, current fatigue showed the highest correlation with VAS-pain (r: 0.96). This was followed by DAS28 and HAQ, respectively (r: 0.77 and 0.70) (p=0.000). Duration items of FSI (number of days fatigued, amount of time fatigued) were significantly correlated with DAS28, HAQ, and VAS pain (p=0.000). Also there were significant positive correlations between interference scale of FSI and DAS28, HAQ, and VAS-pain (r: 0.68, 0.61 and 0.67, respectively) (p=0.000). None of FSI subgroups showed statistically significant correlation with di­sease duration. CONCLUSIONS: Fatigue is strongly associated with severity of pain, disease activity and functional status. Fatigue should be included in clinical practice and clinical trials as a RA outcome measure.


Subject(s)
Arthritis, Rheumatoid/complications , Fatigue/etiology , Adult , Aged , Arthritis, Rheumatoid/physiopathology , Disability Evaluation , Female , Health Status , Humans , Male , Middle Aged , Pain Measurement , Severity of Illness Index , Young Adult
2.
Rheumatol Int ; 31(6): 823-6, 2011 Jun.
Article in English | MEDLINE | ID: mdl-20680284

ABSTRACT

Rheumatoid arthritis (RA) is a systemic disease that causes disability. Disability and quality of life indexes are used in the assessment and treatment of patients with RA. Disability of Arm, Shoulder and Hand Questionnaire (DASH) is a patient-based outcome measurement developed to evaluate the upper extremities. The aim of this study was to investigate the clinical relevance of DASH in RA patients and the relationship between disease activity and health-related quality of life measurements. One hundred and sixty-six RA patients were included in the study. Disease activity was measured with Disease Activity Score 28 (DAS28), Simplified Disease Activity Index (SDAI), and Clinical Disease Activity Index (CDAI). The DASH questionnaire, Short-Form 36 (SF-36), and Health Assessment Questionnaire (HAQ) were completed by all patients. The DASH score moderately correlated with DAS28 (r=0.672), SDAI (r=0.586) and CDAI (r=0.565). When the patients were grouped according to the activity obtained using the three disease activity measurements, DASH score was statistically significantly higher with higher disease activity (P<0.001). A high correlation (r=0.883) was found between DASH and HAQ (r=0.883). The SF-36 scores were correlated with DASH (r=-0.785 with physical component, r=-0.619 with mental component). DASH scores correlate with disease activity indices, functional disability and QoL and can be used in the assessment of upper extremities in patients with RA.


Subject(s)
Arthritis, Rheumatoid/diagnosis , Arthritis, Rheumatoid/physiopathology , Disability Evaluation , Hand Joints/physiopathology , Health Status , Shoulder Joint/physiopathology , Arthritis, Rheumatoid/complications , Female , Hand Strength , Humans , Male , Middle Aged , Pain/etiology , Pain/physiopathology , Quality of Life , Range of Motion, Articular , Severity of Illness Index , Surveys and Questionnaires
3.
J Hand Surg Am ; 35(5): 736-42, 2010 May.
Article in English | MEDLINE | ID: mdl-20381979

ABSTRACT

PURPOSE: The aim of this study was to compare the functional and radiographic outcomes of dorsally displaced distal radius fractures treated by closed reduction plaster cast fixation (CRPCF) and external fixation (EF) in patients 65 years and older. METHODS: This retrospective and nonrandomized study comprised 46 consecutive patients older than 65 years who had distal radial fractures. Patients were divided into 2 groups according to treatment: a CRPCF group and an EF group. All the fractures were dorsally displaced and AO/ASIF type A or C, without articular stepoff or gap. Cases were evaluated based on the criteria of Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire score, wrist range of motion, and radiologic results. RESULTS: The mean follow-up period was 25.1 months. Union was achieved in all cases. Although it was not a statistically significant difference, posttreatment complications were more common in the CRPCF group (10 patients) than in the EF group (7 patients). In the CRPCF group, most complications were discomfort from the cast, whereas in the EF group, most were pin site infections. The average wrist extension and ulnar deviation (clinically) and palmar tilt and radial height (radiologically) were statistically better in the EF group at the final follow-up. The mean DASH scores were 20.3 in the CRPCF group and 21.9 in the EF group. There was no statistically significant difference in the DASH scores; in wrist flexion, radial deviation, pronation, supination, grip strength, or pinch strength (clinically); or in ulnar variance or radial inclination (radiologically). There was no correlation between the DASH scores and palmar tilt and ulnar variance. CONCLUSIONS: We concluded that both CRPCF and EF are useful methods for distal radius fractures in elderly patients. The results showed significant differences in wrist extension and ulnar deviation.


Subject(s)
Casts, Surgical , Colles' Fracture/therapy , Fracture Fixation , Aged , Casts, Surgical/adverse effects , Colles' Fracture/diagnostic imaging , External Fixators , Female , Fracture Fixation/adverse effects , Humans , Male , Radiography
4.
Neurol India ; 57(4): 434-7, 2009.
Article in English | MEDLINE | ID: mdl-19770544

ABSTRACT

BACKGROUND: Traumatic injury of peripheral nerves is a worldwide problem and can result in significant disability. Management of peripheral nerve injuries (PNIs) requires accurate localization and the assessment of severity of the lesion. AIM: The purpose of this study is to analyze the data of patients with PNIs referred for electromyography to a tertiary care hospital. MATERIALS AND METHODS: This is a retrospective study of clinical and electromyographic data of patients with PNIs seen over a period of eight-years (1999-2007) in a tertiary hospital. The data collected included: Demographic data, cause, type of lesion, anatomical location of the lesion, and the mechanism of lesion. RESULTS: During the study period 938 patients were seen with nerve injuries and the distribution of nerve injuries was: PNIs: 1,165; brachial plexus lesions: 76; and lumbar plexus lesions: 7. The mean age was 31.8 years (range 2-81 years) and the male to female ratio was 2.4:1. The most frequent nerve injuries were ulnar nerve in the upper extremity and sciatic nerve in the lower extremity. The most common cause of nerve injury was motor vehicle accidents. Two-thirds of the PNIs were partial. CONCLUSION: This study can serve as a guide to determine the epidemiology and classification of traumatic peripheral and plexus injuries.


Subject(s)
Peripheral Nervous System Diseases/etiology , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Child , Child, Preschool , Databases, Bibliographic/statistics & numerical data , Electromyography/methods , Female , Humans , Iatrogenic Disease/epidemiology , Male , Middle Aged , Peripheral Nervous System Diseases/classification , Peripheral Nervous System Diseases/epidemiology , Retrospective Studies , Severity of Illness Index , Sex Factors , Young Adult
5.
Rheumatol Int ; 30(1): 63-7, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19373468

ABSTRACT

Most of musculoskeletal diseases involve pain and reduced physical functioning. Recognition of the coexistence of more than one musculoskeletal disease is important because they are relatively common and has a substantial impact on health-related quality of life (HRQoL). Our aim was to compare the results of four generic QoL questionnaires--QoL-5, Nottingham Health Profile (NHP), Short Form (SF)-6D, and Visual Analogue Scale (VAS)--in five different patient groups. Two hundred and one patients representing five different disease groups (knee osteoarthritis, osteoporosis, back pain, rheumatoid arthritis and ankylosing spondylitis), randomly selected through the Ankara Numune Education and Research Hospital Physical Medicine and Rehabilitation Outpatient Clinic, were included in the study. Scores indicating low QoL for each of the five diseases compared are reported. Patients in each disease group stated high disability. No strong correlation between any of the scales could be determined, and NHP was identified as the only scale able to differentiate between the diseases. Many instruments are available for measuring HRQoL. The QoL-5, NHP, SF-6D, and VAS are four commonly used generic (i.e., not disease-specific) measures for quantifying HRQoL in patients with musculoskeletal disorders. Most studies have focused on only one musculoskeletal disease, but comorbidity of musculoskeletal disorders is common. We emphasize in this study the effect of multiple musculoskeletal diseases on HRQoL.


Subject(s)
Musculoskeletal Diseases/diagnosis , Quality of Life , Surveys and Questionnaires , Adult , Aged , Analysis of Variance , Chi-Square Distribution , Diagnosis, Differential , Disability Evaluation , Female , Humans , Male , Middle Aged , Musculoskeletal Diseases/physiopathology , Musculoskeletal Diseases/psychology , Pain Measurement , Predictive Value of Tests , Turkey
6.
Rheumatol Int ; 29(12): 1435-9, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19288264

ABSTRACT

In this study serum homocystein (Hcy) level was measured and its relationship with disease activity criteria and treatment protocols was investigated in ankylosing spondylitis (AS) patients. Ninety-two AS patients and 58 healthy individuals were recruited. Erythrocyte sedimentation rate and serum C-reactive protein were determined. Bath AS disease activity index and Bath AS functional index were calculated. Serum Hcy levels >15 micromol/l were considered as hyperhomocysteinemia. The mean serum homocysteine levels were 14.40 and 12.60 micromol/l in patients with AS and the control group, respectively, and the difference between two groups was significant. While there was no significant difference between the sulfasalazine (SSZ) group with 14.25 micromol/l mean Hcy level and the methotrexate (MTX)/SSZ group with 16.05 micromol/l, there was a statistically significant difference between the Hcy levels of these two groups and Hcy level of 12.15 micromol/l of the non-steroidal anti-inflammatory drugs group, and 12.60 micromol/l Hcy level of the control group. Mean serum Hcy level was 13.65 micromol/l in patients with active AS and 14.60 micromol/l in patients with inactive AS, and there was no significant difference between the groups. In our study serum Hcy level was found to be significantly higher in patients with AS than in healthy control subjects. Especially for the AS patients receiving MTX and SSZ treatment without folic acid supplementation, addition of folic acid to their therapy may decrease the risk of cardiovascular disease which in turn decreases the mortality in these patients, but further prospective studies are needed for supporting these results.


Subject(s)
Antirheumatic Agents/therapeutic use , Homocysteine/blood , Severity of Illness Index , Spondylitis, Ankylosing/blood , Spondylitis, Ankylosing/drug therapy , Adult , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Biomarkers/blood , Blood Sedimentation , C-Reactive Protein/metabolism , Cardiovascular Diseases/prevention & control , Case-Control Studies , Drug Therapy, Combination , Folic Acid/therapeutic use , Humans , Methotrexate/therapeutic use , Middle Aged , Spondylitis, Ankylosing/diagnosis , Sulfasalazine/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...